Bulk Manufacturer of Controlled Substances Application: Euticals, Inc., 3978-3979 [2015-01312]
Download as PDF
<![CDATA[
emcdonald on DSK67QTVN1PROD with NOTICES
3978
Federal Register / Vol. 80, No. 16 / Monday, January 26, 2015 / Notices
207, subpart D; in these proceedings,
entries of appearance will be considered
timely if filed no later than 14 days after
publication of this notice in the Federal
Register. The Secretary will prepare a
public service list containing the names
and addresses of all persons, or their
representatives, who are parties to these
reviews upon the expiration of the
period for filing entries of appearance.
Limited disclosure of business
proprietary information (BPI) under an
administrative protective order (APO)
and BPI service list. Pursuant to section
207.7(a) of the Commission’s rules, the
Secretary will make BPI gathered in
these reviews available to authorized
applicants representing interested
parties (as defined in 19 U.S.C. 1677(9))
who are parties to the reviews under the
APO issued in the proceedings,
provided that the application is made
not later than 14 days after the
publication of this notice in the Federal
Register. A separate service list will be
maintained by the Secretary for those
parties authorized to receive BPI under
the APO.
Written submissions. Parties will have
the opportunity to file two written
submissions in these reviews. The first
submission may contain any factual
information pertinent to the
determinations that the Commission is
required to make pursuant to sections
704(h) and 734(h) of the Act and
arguments concerning the significance
of this information, or information in
the record of Sugar from Mexico, Inv.
Nos. 701–TA–513 and 731–TA–1249
(Preliminary) (‘‘the preliminary phase
investigations’’) to these determinations.
The Commission is particularly
interested in receiving parties’ views
concerning the following issues:
• What information the Commission
should use to assess whether the
injurious effect of the imports of the
subject merchandise is eliminated
completely by the suspension
agreements
• The time period the Commission
should evaluate in assessing whether
the injurious effect of the imports of
the subject merchandise is eliminated
completely by the suspension
agreements
• The standard the Commission should
use to assess whether the injurious
effect of imports of the subject
merchandise is ‘‘eliminated
completely’’
• The use of the singular word ‘‘effect’’
in the statute and whether the
Commission is permitted or required
to assess any ‘‘effect’’ other than that
resulting from pricing of the subject
merchandise under the suspension
agreements.
VerDate Sep<11>2014
18:48 Jan 23, 2015
Jkt 235001
• Whether the Commission’s analysis of
‘‘injurious effect’’ incorporates any
analysis of injurious effect of imports
of the subject merchandise caused by
the suspension agreement itself.
Parties need not resubmit any
information that is in the record of the
preliminary phase investigations, as this
information will be included in the
record of these reviews. This first
submission shall be filed no later than
Tuesday, February 10, 2015.
The second submission should
respond to arguments and information
submitted in the first submissions as
well as other information in the record.
These submissions may contain no more
than 20 pages of textual material,
double-spaced and single-sided, when
printed out on paper measuring 8.5 x 11
inches. They may also include an
appendix which may contain responses
to specific requests from Commissioners
and staff. Aside from the material in the
appendix, the second submission may
not contain new factual information.
This second submission shall be filed
no later than Thursday, February 26,
2015.
If written submissions contain BPI,
they must conform with the
requirements of sections 201.6, 207.3,
and 207.7 of the Commission’s rules.
Please consult the Commission’s rules,
as amended, 76 FR 61937 (Oct. 6, 2011)
and the Commission’s Handbook on
Filing Procedures, 76 FR 62092 (Oct. 6,
2011), available on the Commission’s
Web site at https://edis.usitc.gov.
In accordance with sections 201.16(c)
and 207.3 of the rules, each document
filed by a party to the review must be
served on all other parties to the review
(as identified by either the public or BPI
service list), and a certificate of service
must be timely filed. The Secretary will
not accept a document for filing without
a certificate of service.
Opportunities for Oral Presentation:
The Commission will convene a
proceeding on Thursday, February 19,
2015, at 9:30 a.m. at 500 E Street SW.,
Washington, DC to receive oral
presentations from parties to the
reviews. The Commission will provide
further information about the nature of
this proceeding to the parties at a later
date.
Authority: These reviews are being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to section 207.12 of the
Commission’s rules.
Issued: January 21, 2015.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
By order of the Commission.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2015–01264 Filed 1–23–15; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[USITC SE–15–006]
Government in the Sunshine Act
Meeting Notice
United
States International Trade Commission.
TIME AND DATE: February 5, 2015 at 2
p.m.
PLACE: Room 101, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED: 1. Agendas
for future meetings: none.
2. Minutes.
3. Ratification List.
4. Vote in Inv. Nos. 701–TA–458 and
731–TA–1154 (Review) (Certain Kitchen
Appliance Shelving and Racks from
China). The Commission is currently
scheduled to complete and file its
determinations and views of the
Commission on February 24, 2015.
5. Outstanding action jackets: none.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
AGENCY HOLDING THE MEETING:
Issued: January 21, 2015.
By order of the Commission.
William R. Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2015–01387 Filed 1–22–15; 11:15 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Euticals, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before March 27, 2015.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
DATES:
E:\FR\FM\26JAN1.SGM
26JAN1
Federal Register / Vol. 80, No. 16 / Monday, January 26, 2015 / Notices
Drug Enforcement Administration
Dated: January 9, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[Docket No. DEA–392]
[FR Doc. 2015–01313 Filed 1–23–15; 8:45 am]
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
DEPARTMENT OF JUSTICE
SUPPLEMENTARY INFORMATION:
ACTION:
The Attorney General has delegated
his authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to section 7 of 28 CFR pt. 0,
subpt. R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on May 29,
2014, Euticals, Inc., 2460 W. Bennett
Street, Springfield, Missouri 65807–
1229, applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Controlled substance
Schedule
emcdonald on DSK67QTVN1PROD with NOTICES
Gamma
Hydroxybutyric
Acid
(2010).
Amphetamine (1100) ....................
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Phenylacetone (8501) ..................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Oripavine (9330) ...........................
Tapentadol (9780) ........................
I
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution and sale to its
customers.
In reference to Amphetamine (1100),
the company plans to acquire the listed
controlled substance in bulk from a
domestic source in order to manufacture
other controlled substances in bulk for
distribution to its customers.
Dated: January 9, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–01312 Filed 1–23–15; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
18:48 Jan 23, 2015
Jkt 235001
3979
BILLING CODE P
Bulk Manufacturer of Controlled
Substances Application: Halo
Pharmaceutical, Inc.
Notice of application.
Drug Enforcement Administration
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before March 27, 2015.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
The Attorney General has delegated
his authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers, of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to section 7 of 28 CFR pt. 0,
subpt. R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on July 21,
2014, Halo Pharmaceutical, Inc., 30
North Jefferson Road, Whippany, New
Jersey 07981, applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
DATES:
Controlled substance
Dihydromorphine (9145) ...............
Hydromorphone (9150) ................
Schedule
I
II
The company plans to manufacture
Hydromorphone HCl for sale to other
manufacturers and to manufacture other
controlled substances for distribution to
its customers. Dihydromorphine is an
intermediate in the manufacture of
Hydromorphone and is not for
commercial distribution.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Fisher Clinical Services,
Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before February 25, 2015. Such
persons may also file a written request
for a hearing on the application
pursuant to 21 CFR 1301.43 on or before
February 25, 2015.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of importers,
of controlled substances (other than
final orders in connection with
suspension, denial, or revocation of
registration) has been redelegated to the
Deputy Assistant Administrator of the
DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to section 7 of 28 CFR pt. 0,
subpt. R, App.
In accordance with 21 CFR
1301.34(a), this is notice that on June
16, 2014, Fisher Clinical Services, Inc.
7554 Schantz Road, Allentown,
Pennsylvania 18106 applied to be
registered as an importer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\26JAN1.SGM
26JAN1
]]>Agencies
[Federal Register Volume 80, Number 16 (Monday, January 26, 2015)]
[Notices]
[Pages 3978-3979]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01312]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Euticals,
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before March 27, 2015.
ADDRESSES: Written comments should be sent to: Drug Enforcement
[[Page 3979]]
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152. Request for
hearings should be sent to: Drug Enforcement Administration, Attention:
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
The Attorney General has delegated his authority under the
Controlled Substances Act to the Administrator of the Drug Enforcement
Administration (DEA), 28 CFR 0.100(b). Authority to exercise all
necessary functions with respect to the promulgation and implementation
of 21 CFR part 1301, incident to the registration of manufacturers,
distributors, and dispensers of controlled substances (other than final
orders in connection with suspension, denial, or revocation of
registration) has been redelegated to the Deputy Assistant
Administrator of the DEA Office of Diversion Control (``Deputy
Assistant Administrator'') pursuant to section 7 of 28 CFR pt. 0,
subpt. R, App.
In accordance with 21 CFR 1301.33(a), this is notice that on May
29, 2014, Euticals, Inc., 2460 W. Bennett Street, Springfield, Missouri
65807-1229, applied to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)........... I
Amphetamine (1100)......................... II
Lisdexamfetamine (1205).................... II
Methylphenidate (1724)..................... II
Phenylacetone (8501)....................... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Oripavine (9330)........................... II
Tapentadol (9780).......................... II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution and sale to its customers.
In reference to Amphetamine (1100), the company plans to acquire
the listed controlled substance in bulk from a domestic source in order
to manufacture other controlled substances in bulk for distribution to
its customers.
Dated: January 9, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-01312 Filed 1-23-15; 8:45 am]
BILLING CODE P
